Dr Clare Appleby (Liverpool Heart and Chest Hospital, Liverpool, UK) revisits the latest data and discusses whether transcatheter aortic valve implantation (TAVI) should now be considered the default treatment for patients with symptomatic aortic stenosis over surgery.
Has TAVI evolved to become the default treatment for patients with symptomatic AS? If not, what more is needed to convince you?
Should this apply to all approved valves?
In which clinical settings would a patient not be a candidate for TAVI and how do you assess this?
Does durability still need to be assessed alongside factors such as coronary obstruction, longer term?
Filmed in London at BCIS ACI 2020.
Interviewer: Leiah Norcott
Videographer: Natacha Wienand / Dominic Woodruff